IMMUNE-MEDIATED OESOPHAGITIS

IMMUNE-MEDIATED OESOPHAGITIS was reported 72 times

IMMUNE-MEDIATED OESOPHAGITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Programmed Death Receptor-1 Blocking Antibody [EPC] 66 0.0007
1 CTLA-4-directed Blocking Antibody [EPC] 14 0.0003
2 Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] 1 0.0002
3 Programmed Death Ligand-1 Blocker [EPC] 3 0.0001
4 Platinum-based Drug [EPC] 17 0.0001
5 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
6 Folate Analog Metabolic Inhibitor [EPC] 8 0.0000
7 Microtubule Inhibitor [EPC] 3 0.0000
8 Xanthine Oxidase Inhibitor [EPC] 3 0.0000
9 Azole Antifungal [EPC] 2 0.0000
10 Alkylating Drug [EPC] 3 0.0000
11 Nucleoside Analog Antiviral [EPC] 1 0.0000
12 Integrin Receptor Antagonist [EPC] 1 0.0000
13 Vascular Endothelial Growth Factor Inhibitor [EPC] 2 0.0000
14 Vitamin B12 [EPC] 3 0.0000
15 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
16 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
17 Fluoroquinolone Antibacterial [EPC] 1 0.0000
18 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
19 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
20 Kinase Inhibitor [EPC] 4 0.0000
21 alpha-Adrenergic Blocker [EPC] 1 0.0000
22 Vitamin D [EPC] 2 0.0000
23 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
24 Corticosteroid [EPC] 7 0.0000
25 Vitamin C [EPC] 2 0.0000
26 Factor Xa Inhibitor [EPC] 1 0.0000
27 beta-Adrenergic Blocker [EPC] 1 0.0000
28 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
29 Atypical Antipsychotic [EPC] 1 0.0000
30 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
31 Proton Pump Inhibitor [EPC] 1 0.0000